BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/07/2008

FDA Clears Mazindol Tablets for Approval

The FDA has determined that SANOREX (mazindol) Tablets, 1 and 2 milligrams, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications (ANDAs) for the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →